Application Information

This drug has been submitted to the FDA under the reference 203341/001.

Names and composition

"BOSULIF" is the commercial name of a drug composed of BOSUTINIB MONOHYDRATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
203341/001 BOSULIF BOSUTINIB MONOHYDRATE TABLET/ORAL EQ 100MG BASE
203341/002 BOSULIF BOSUTINIB MONOHYDRATE TABLET/ORAL EQ 500MG BASE

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
203341/001 BOSULIF BOSUTINIB MONOHYDRATE TABLET/ORAL EQ 100MG BASE
203341/002 BOSULIF BOSUTINIB MONOHYDRATE TABLET/ORAL EQ 500MG BASE

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved